Works by Thall, Peter

Results: 136

A phase I-II design based on periodic and continuous monitoring of disease status and the times to toxicity and death.

Published in:

2020

By:

Lee, Juhee;
F. Thall, Peter;
Msaouel, Pavlos;
F Thall, Peter

Publication type:

journal article

A decision-theoretic phase I-II design for ordinal outcomes in two cycles.

Published in:

2016

By:

JUHEE LEE;
PETER F. THALL;
YUAN JI;
MÜLLER, PETER;
Lee, Juhee;
Thall, Peter F;
Ji, Yuan;
Müller, Peter

Publication type:

journal article

Interpreting Randomized Controlled Trials.

Published in:

Cancers, 2023, v. 15, n. 19, p. 4674, doi. 10.3390/cancers15194674

By:

Msaouel, Pavlos;
Lee, Juhee;
Thall, Peter F.

Publication type:

Article

A Causal Framework for Making Individualized Treatment Decisions in Oncology.

Published in:

Cancers, 2022, v. 14, n. 16, p. 3923, doi. 10.3390/cancers14163923

By:

Msaouel, Pavlos;
Lee, Juhee;
Karam, Jose A.;
Thall, Peter F.

Publication type:

Article

Making Patient-Specific Treatment Decisions Using Prognostic Variables and Utilities of Clinical Outcomes.

Published in:

Cancers, 2021, v. 13, n. 11, p. 2741, doi. 10.3390/cancers13112741

By:

Msaouel, Pavlos;
Lee, Juhee;
Thall, Peter F.

Publication type:

Article

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials.

Published in:

Cancers, 2020, v. 12, n. 11, p. 3251, doi. 10.3390/cancers12113251

By:

Le-Rademacher, Jennifer G.;
Hillman, Shauna;
Storrick, Elizabeth;
Mahoney, Michelle R.;
Thall, Peter F.;
Jatoi, Aminah;
Mandrekar, Sumithra J.

Publication type:

Article

Continuous Bayesian adaptive randomization based on event times with covariates.

Published in:

Statistics in Medicine, 2006, v. 25, n. 1, p. 55, doi. 10.1002/sim.2247

By:

Cheung, Ying Kuen;
Inoue, Lurdes Y. T.;
Wathen, J. Kyle;
Thall, Peter F.

Publication type:

Article

Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments.

Published in:

Statistics in Medicine, 2005, v. 24, n. 13, p. 1947, doi. 10.1002/sim.2077

By:

Thall, Peter F.;
Wathen, J. Kyle

Publication type:

Article

Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes.

Published in:

Statistics in Medicine, 2003, v. 22, n. 5, p. 763, doi. 10.1002/sim.1399

By:

Thall, Peter F.;
Wathen, J. Kyle;
Bekele, B. Nebiyou;
Champlin, Richard E.;
Baker, Laurence H.;
Benjamin, Robert S.

Publication type:

Article

Optimal two-stage designs for clinical trials based on safety and efficacy.

Published in:

Statistics in Medicine, 2001, v. 20, n. 7, p. 1023, doi. 10.1002/sim.717

By:

Thall, Peter F.;
Cheng, Su-Chun

Publication type:

Article

Evaluating multiple treatment courses in clinical trials.

Published in:

2000

By:

Thall, Peter F.;
Millikan, Randall E.;
Sung, Hsi-Guang;
Thall, P F;
Millikan, R E;
Sung, H G

Publication type:

journal article

Accrual strategies for phase I trials with delayed patient outcome.

Published in:

1999

By:

Thall, Peter F.;
Jack Lee, J.;
Tseng, Chi-Hong;
Estey, Elihu H.;
Thall, P F;
Lee, J J;
Tseng, C H;
Estey, E H

Publication type:

journal article

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes.

Published in:

1995

By:

Thall, Peter F.;
Simon, Richard M.;
Estey, Elihu H.;
Thall, P F;
Simon, R M;
Estey, E H

Publication type:

journal article

An optimal three-stage design for phase II clinical trials.

Published in:

1994

By:

Ensign, Lisa Garnsey;
Gehan, Edmund A.;
Kamen, Douglas S.;
Thall, Peter F.;
Ensign, L G;
Gehan, E A;
Kamen, D S;
Thall, P F

Publication type:

journal article

A bayesian strategy for screening cancer treatments prior to phase ii clinical evaluation.

Published in:

Statistics in Medicine, 1993, v. 12, n. 13, p. 1197, doi. 10.1002/sim.4780121303

By:

Thall, Peter F.;
Estey, Elihu H.

Publication type:

Article

A bayesian strategy for screening cancer treatments prior to phase ii clinical evaluation.

Published in:

Statistics in Medicine, 1993, v. 12, n. 11, p. 1197, doi. 10.1002/sim.4780121103

By:

Thall, Peter F.;
Estey, Elihu H.

Publication type:

Article

Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.

Published in:

Journal of Neuro-Oncology, 2015, v. 125, n. 1, p. 133, doi. 10.1007/s11060-015-1878-y

By:

Sandberg, David;
Rytting, Michael;
Zaky, Wafik;
Kerr, Marcia;
Ketonen, Leena;
Kundu, Uma;
Moore, Bartlett;
Yang, Grace;
Hou, Ping;
Sitton, Clark;
Cooper, Laurence;
Gopalakrishnan, Vidya;
Lee, Dean;
Thall, Peter;
Khatua, Soumen

Publication type:

Article

Atypical choroid plexus papilloma: clinical experience in the CPT-SIOP-2000 study.

Published in:

Journal of Neuro-Oncology, 2009, v. 95, n. 3, p. 383, doi. 10.1007/s11060-009-9936-y

By:

Wrede, Brigitte;
Hasselblatt, Martin;
Peters, Ove;
Thall, Peter F.;
Kutluk, Tezer;
Moghrabi, Albert;
Mahajan, Anita;
Rutkowski, Stefan;
Diez, Blanca;
Xuemei Wang;
Pietsch, Torsten;
Kortmann, Rolf-Dieter;
Paulus, Werner;
Jeibmann, Astrid;
Wolff, Johannes E. A.

Publication type:

Article

Two-stage selection and testing designs for comparative clinical trials.

Published in:

Biometrika, 1988, v. 75, n. 2, p. 303

By:

THALL, PETER F.;
SIMON, RICHARD;
ELLENBERG, SUSAN S.

Publication type:

Article

Estimating Genomic Category Probabilities from Fluorescent in Situ Hybridization Counts with Misclassification.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 1996, v. 45, n. 4, p. 431, doi. 10.2307/2986066

By:

Thall, Peter F.;
Jacoby, Derek;
Zimmerman, Stuart O.

Publication type:

Article

High-risk myeloma and minimal residual disease postautologous-HSCT predict worse outcomes.

Published in:

Leukemia & Lymphoma, 2019, v. 60, n. 2, p. 442, doi. 10.1080/10428194.2018.1485908

By:

Hu, Bei;
Thall, Peter;
Milton, Denái R;
Sasaki, Koji;
Bashir, Qaiser;
Shah, Nina;
Popat, Uday;
Hosing, Chitra;
Nieto, Yago;
Delgado, Ruby;
Champlin, Richard;
Qazilbash, Muzaffar H.;
Patel, Krina;
Manasanch, Elisabet;
Weber, Donna;
Thomas, Sheeba;
Orlowski, Robert Z.;
Lin, Pei;
Jorgensen, Jeffrey

Publication type:

Article

BAGS: A Bayesian Adaptive Group Sequential Trial Design With Subgroup-Specific Survival Comparisons.

Published in:

Journal of the American Statistical Association, 2021, v. 116, n. 533, p. 322, doi. 10.1080/01621459.2020.1837142

By:

Lin, Ruitao;
Thall, Peter F.;
Yuan, Ying

Publication type:

Article

A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes.

Published in:

Journal of the American Statistical Association, 2018, v. 113, n. 523, p. 1255, doi. 10.1080/01621459.2017.1340887

By:

Murray, Thomas A.;
Yuan, Ying;
Thall, Peter F.

Publication type:

Article

Robust Treatment Comparison Based on Utilities of Semi-Competing Risks in Non-Small-Cell Lung Cancer.

Published in:

Journal of the American Statistical Association, 2017, v. 112, n. 517, p. 11, doi. 10.1080/01621459.2016.1176926

By:

Murray, Thomas A.;
Thall, Peter F.;
Yuan, Ying;
McAvoy, Sarah;
Gomez, Daniel R.

Publication type:

Article

Rejoinder.

Published in:

Journal of the American Statistical Association, 2016, v. 111, n. 515, p. 948, doi. 10.1080/01621459.2016.1200917

By:

Xu, Yanxun;
Müller, Peter;
Wahed, Abdus S.;
Thall, Peter

Publication type:

Article

Bayesian Nonparametric Estimation for Dynamic Treatment Regimes With Sequential Transition Times.

Published in:

Journal of the American Statistical Association, 2016, v. 111, n. 515, p. 921, doi. 10.1080/01621459.2015.1086353

By:

Xu, Yanxun;
Müller, Peter;
Wahed, Abdus S.;
Thall, Peter F.

Publication type:

Article

Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.

Published in:

Journal of the American Statistical Association, 2015, v. 110, n. 510, p. 711, doi. 10.1080/01621459.2014.926815

By:

Lee, Juhee;
Thall, Peter F.;
Ji, Yuan;
Müller, Peter

Publication type:

Article

Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome.

Published in:

Journal of the American Statistical Association, 2014, v. 109, n. 507, p. 931, doi. 10.1080/01621459.2014.904789

By:

Thall, Peter F.;
Nguyen, Hoang Q.;
Zohar, Sarah;
Maton, Pierre

Publication type:

Article

Using Data Augmentation to Facilitate Conduct of Phase I–II Clinical Trials With Delayed Outcomes.

Published in:

Journal of the American Statistical Association, 2014, v. 109, n. 506, p. 525, doi. 10.1080/01621459.2014.881740

By:

Jin, Ick Hoon;
Liu, Suyu;
Thall, Peter F.;
Yuan, Ying

Publication type:

Article

Dose-Finding Based on Multiple Toxicities in a Soft Tissue Sarcoma Trial.

Published in:

Journal of the American Statistical Association, 2004, v. 99, n. 465, p. 26, doi. 10.1198/016214504000000043

By:

Bekele, B. Nebiyou;
Thall, Peter F.

Publication type:

Article

Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule.

Published in:

Statistics in Medicine, 2024, v. 43, n. 29, p. 5583, doi. 10.1002/sim.10254

By:

Lee, Juhee;
Thall, Peter F.

Publication type:

Article

Precision Bayesian phase I‐II dose‐finding based on utilities tailored to prognostic subgroups.

Published in:

Statistics in Medicine, 2021, v. 40, n. 24, p. 5199, doi. 10.1002/sim.9120

By:

Lee, Juhee;
Thall, Peter F.;
Msaouel, Pavlos

Publication type:

Article

Bayesian variable selection based on clinical relevance weights in small sample studies-Application to colon cancer.

Published in:

2019

By:

Boulet, Sandrine;
Ursino, Moreno;
Thall, Peter;
Jannot, Anne‐Sophie;
Zohar, Sarah;
Jannot, Anne-Sophie

Publication type:

journal article

Utility-based designs for randomized comparative trials with categorical outcomes.

Published in:

2016

By:

Murray, Thomas A.;
Thall, Peter F.;
Yuan, Ying

Publication type:

journal article

Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen.

Published in:

Sequential Analysis, 2009, v. 28, n. 1, p. 41, doi. 10.1080/07474940802619170

By:

Thall, Peter F.

Publication type:

Article

A Bayesian feature allocation model for identifying cell subpopulations using CyTOF data.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2023, v. 72, n. 3, p. 718, doi. 10.1093/jrsssc/qlad029

By:

Lui, Arthur;
Lee, Juhee;
Thall, Peter F;
Daher, May;
Rezvani, Katy;
Basar, Rafet

Publication type:

Article

Utility‐based Bayesian personalized treatment selection for advanced breast cancer.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2022, v. 71, n. 5, p. 1605, doi. 10.1111/rssc.12582

By:

Lee, Juhee;
Thall, Peter F.;
Lim, Bora;
Msaouel, Pavlos

Publication type:

Article

Bayesian non‐parametric survival regression for optimizing precision dosing of intravenous busulfan in allogeneic stem cell transplantation.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 3, p. 809, doi. 10.1111/rssc.12331

By:

Xu, Yanxun;
Thall, Peter F.;
Hua, William;
Andersson, Borje S.

Publication type:

Article

Optimizing natural killer cell doses for heterogeneous cancer patients on the basis of multiple event times.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2019, v. 68, n. 2, p. 461, doi. 10.1111/rssc.12271

By:

Lee, Juhee;
Thall, Peter F.;
Rezvani, Katy

Publication type:

Article

Parametric dose standardization for optimizing two-agent combinations in a phase I-II trial with ordinal outcomes.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2017, v. 66, n. 1, p. 201, doi. 10.1111/rssc.12162

By:

Thall, Peter F.;
Nguyen, Hoang Q.;
Zinner, Ralph G.

Publication type:

Article

Bayesian group sequential clinical trial design using total toxicity burden and progression-free survival.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2016, v. 65, n. 2, p. 273, doi. 10.1111/rssc.12117

By:

Hobbs, Brian P.;
Thall, Peter F.;
Lin, Steven H.

Publication type:

Article

Evaluating joint effects of induction-salvage treatment regimes on overall survival in acute leukaemia.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2013, v. 62, n. 1, p. 67, doi. 10.1111/j.1467-9876.2012.01048.x

By:

Wahed, Abdus S.;
Thall, Peter F.

Publication type:

Article

Estimating progression-free survival in paediatric brain tumour patients when some progression statuses are unknown.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2012, v. 61, n. 1, p. 135, doi. 10.1111/j.1467-9876.2011.01002.x

By:

Yuan, Ying;
Thall, Peter F.;
Wolff, Johannes E.

Publication type:

Article

A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer.

Published in:

Journal of the Royal Statistical Society: Series C (Applied Statistics), 2010, v. 59, n. 1, p. 19, doi. 10.1111/j.1467-9876.2009.00680.x

By:

Morita, Satoshi;
Thall, Peter F.;
Bekele, B. Nebiyou;
Mathew, Paul

Publication type:

Article

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck.

Published in:

2001

By:

Tseng, Jennifer E.;
Glisson, Bonnie S.;
Khuri, Fadlo R.;
Shin, Dong M.;
Myers, Jeffrey N.;
El-Naggar, Adel K.;
Roach, Jennifer S.;
Ginsberg, Lawrence E.;
Thall, Peter F.;
Wang, Xuemei;
Teddy, Stephanie;
Lawhorn, Kristie N.;
Zentgraf, Rebecca E.;
Steinhaus, Ganene D.;
Pluda, James M.;
Abbruzzese, James L.;
Hong, Waun Ki;
Herbst, Roy S.;
Tseng, J E;
Glisson, B S

Publication type:

journal article

A Phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.

Published in:

Cancer (0008543X), 1999, v. 86, n. 11, p. 2291, doi. 10.1002/(SICI)1097-0142(19991201)86:11<2291::AID-CNCR17>3.0.CO;2-A

By:

Gershenson, David M.;
Morris, Mitchell;
Burke, Thomas W.;
Levenback, Charles;
Wolf, Judith;
Lee, J. Jack;
Thall, Peter F.;
Atkinson, E. Neely;
Silva, Elvio G.;
Wharton, J. Taylor

Publication type:

Article

Selenium and Vitamin E: Cell Type- and Intervention-Specific Tissue Effects in Prostate Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 5, p. 306, doi. 10.1093/jnci/djn512

By:

Tsavachidou, Dimitra;
McDonnell, Timothy J.;
Sijin Wen;
Xuemei Wang;
Vakar-Lopez, Funda;
Pisters, Louis L.;
Pettaway, Curtis A.;
Wood, Christopher G.;
Kim-Anh Do;
Thall, Peter F.;
Stephens, Clifton;
Efstathiou, Eleni;
Taylor, Robert;
Menter, David G.;
Troncoso, Patricia;
Lippman, Scott M.;
Logothetis, Christopher J.;
Jeri Kim

Publication type:

Article

Response.

Published in:

2008

By:

Millikan, Randall E.;
Logothetis, Christopher J.;
Thall, Peter F.

Publication type:

Letter

Adaptive Therapy for Androgen-Independent Prostate Cancer: A Randomized Selection Trial of Four Regimens.

Published in:

JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 21, p. 1613, doi. 10.1093/jnci/djm189

By:

Thall, Peter F.;
Logothetis, Christopher;
Pagliaro, Lance C.;
Wen, Sijin;
Brown, Melissa A.;
Williams, Dallas;
Millikan, Randall E.

Publication type:

Article

Clinical trial design as a decision problem.

Published in:

Applied Stochastic Models in Business & Industry, 2017, v. 33, n. 3, p. 296, doi. 10.1002/asmb.2222

By:

Müller, Peter;
Xu, Yanxun;
Thall, Peter F.

Publication type:

Article